Multi-Center, Randomized Controlled Study of the NeuRx Diaphragm Pacing System (DPS) in Participants with Amyotrophic Lateral Sclerosis

The study is being conducted to determine if DPS treatment for people with ALS and hypoventilation is associated with improved survival or diaphragm function. The primary objective of the study is to conduct a multi-center, randomized controlled clinical trial comparing standard of care (control) to diaphragm stimulator treatment with the NeuRx® Diaphragm Pacing System™ (DPS) with respect to survival. The secondary objective of the study is to conduct a multi-center, randomized controlled clinical trial to compare standard of care treatment (control) to DPS in ALS subjects with hypoventilation.

Principal Investigator

CONTACT INFORMATION

Primary Contact:
Shirley Paulose
(650) 724-3792